TWC
TEVA icon

TD Waterhouse Canada’s Teva Pharmaceuticals TEVA Stock Holding History

TD Waterhouse Canada’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.25M Buy
186,889
+9,340
+5% +$311K 0.02% 363
2026
Q1 		$5.37M Buy
177,549
+163,030
+1,123% +$5.25M 0.02% 370
2025
Q4 		$453K Buy
14,519
+700
+5% +$17.2K ﹤0.01% 715
2025
Q3 		$277K Sell
13,819
-200
-1% -$3.51K ﹤0.01% 821
2025
Q2 		$233K Sell
14,019
-1,083
-7% -$17.5K ﹤0.01% 796
2025
Q1 		$231K Sell
15,102
-497
-3% -$8.88K ﹤0.01% 765
2024
Q4 		$344K Sell
15,599
-5,100
-25% -$92.8K ﹤0.01% 690
2024
Q3 		$366K Buy
20,699
+3,900
+23% +$68.3K ﹤0.01% 661
2024
Q2 		$274K Hold
16,799
– – ﹤0.01% 704
2024
Q1 		$241K Sell
16,799
-300
-2% -$3.78K ﹤0.01% 738
2023
Q4 		$192K Sell
17,099
-1,707
-9% -$15.9K ﹤0.01% 686
2023
Q3 		$194K Buy
18,806
+10,750
+133% +$100K ﹤0.01% 648
2023
Q2 		$64.1K Sell
8,056
-3,774
-32% -$30.6K ﹤0.01% 871
2023
Q1 		$113K Sell
11,830
-327
-3% -$3.23K ﹤0.01% 746
2022
Q4 		$122K Buy
12,157
+600
+5% +$5.24K ﹤0.01% 721
2022
Q3 		$101K Sell
11,557
-450
-4% -$3.98K ﹤0.01% 774
2022
Q2 		$98.8K Buy
12,007
+2,000
+20% +$17.4K ﹤0.01% 805
2022
Q1 		$97.6K Buy
10,007
+513
+5% +$4.28K ﹤0.01% 850
2021
Q4 		$84.8K Buy
+9,494
New +$85.7K ﹤0.01% 910

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

TD Waterhouse Canada's TEVA Position: Q2 2026 in Review

TD Waterhouse Canada increased its Teva Pharmaceuticals (TEVA) stake by 5.3% in Q2 2026, buying an estimated $311K and bringing the position to 186,889 shares worth $6.25M. The position accounts for 0.02% of the portfolio, ranked #363.

TD Waterhouse Canada first reported a position in TEVA in Q4 2021 and has held it in 19 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • TD Waterhouse Canada held 186,889 shares of Teva Pharmaceuticals worth $6.25M as of Q2 2026.
  • TD Waterhouse Canada bought 9,340 Teva Pharmaceuticals shares in Q2 2026, an estimated $311K.
  • Teva Pharmaceuticals made up 0.02% of TD Waterhouse Canada's portfolio in Q2 2026, its #363 holding.
  • TD Waterhouse Canada first reported a position in Teva Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.